Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older

September 17, 2024 11:00 AM

CAMBRIDGE, MA / ACCESSWIRE / September 17, 2024 / Moderna Inc (Nasdaq:MRNA) today announced that Health Canada has authorized its updated COVID-19 vaccine, SPIKEVAX® KP.2 variant, to help prevent COVID-19 in individuals six months of age and older. Moderna's updated COVID-19 vaccine targets the KP.2 sub-lineage of SARS-CoV-2. With vaccines ready, Moderna will begin delivery of updated doses to the Public Health Agency of Canada, ensuring supply...

Read more

Tech Fairy Godmother Launches Revolutionary Software Training Program for Young Women in Jamaica

September 17, 2024 10:00 AM

Deadline to Apply is October 25, 2024BALTIMORE, MD / ACCESSWIRE / September 17, 2024 / In an exciting leap towards greater diversity in technology, VAULT Technologies proudly announces the launch of the VAULT Scholars Software Developer Training Program. This transformative initiative, led by Tiffany Tate, dubbed the "Tech Fairy Godmother," and the mastermind behind the acclaimed PrepMod platform, aims to empower young women in Jamaica, ages 17...

Read more

Ludwig Announces Acquisition of Intellectual Property and Patent

September 17, 2024 9:35 AM

SPARKS, NV / ACCESSWIRE / September 17, 2024 / Ludwig Enterprises, Inc., (OTC PINK:LUDG), a USA-based biotechnology company, is pleased to announce it has acquired all the intellectual property and patent of the mRNA Neuro Panel and Serotonin Assay, along with all the data accumulated testing these Assays.Significance of acquisition:Allows use of mRNA genetic biomarkers to study inflammatory changes in the brain in such diseases as autism,...

Read more

Scientific Industries to Present at the Craig-Hallum Bioprocessing Conference on September 19, 2024

September 17, 2024 9:20 AM

Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today that John Nicols, Chairman of Scientific Bioprocessing ("SBI") and John Moore, Chairman of the Company, will participate in Craig-Hallum Bioprocessing Conference on Thursday, September 19, 2024. Messrs. Nicols and Moore will be featured speakers in a fireside chat moderated by Matthew Hewitt,...

Read more

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit

September 17, 2024 9:15 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced its participation at upcoming mRNA events in Boston this week:3rd Annual mRNA Process Development & Manufacturing Summit - members of Applied DNA's Biotherapeutics Sales and Business Development teams (collectively 'LineaRx,' a majority-owned Applied DNA company) will attend the 3rd Annual mRNA Process Development & Manufacturing...

Read more

DirectTrust(R) Announces Launch of New Cybersecurity Workgroup

September 17, 2024 9:05 AM

WASHINGTON, DC / ACCESSWIRE / September 17, 2024 / DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare data exchange through standards, accreditation, and other services, today announced the formation of the DirectTrust Cybersecurity Workgroup, a collaborative initiative designed to bring together healthcare industry professionals to tackle pressing cybersecurity issues. The Workgroup will focus on...

Read more

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application

September 17, 2024 9:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced it has received a follow-on order valued at more than $500,000 for a quantity of Linea™ DNA from a global manufacturer of in vitro diagnostics (IVDs). The follow-on order was placed under a long-standing supply agreement for the bulk manufacture of Linea DNA (non-therapeutic) used in the manufacture of a cancer...

Read more

Veterans Bridge Home Welcomes New Board Members With Experience Leading Private, Non-Profit and Public Sectors

September 17, 2024 9:00 AM

CHARLOTTE, NC / ACCESSWIRE / September 17, 2024 / Veterans Bridge Home (VBH), a leading non-profit supporting veterans and their families across the Carolinas, proudly announces the addition of five esteemed professionals to its board of directors. These new members bring vast experience in military service and corporate leadership, enhancing VBH's mission to help veterans transition smoothly into civilian life. "We are thrilled to welcome...

Read more

World Tumor Registry Partners With PathPresenter to Launch a World-Wide Educational Platform to Improve Cancer Diagnosis

September 17, 2024 9:00 AM

MONTVILLE, NJ / ACCESSWIRE / September 17, 2024 / The World Tumor Registry ("WTR"), a comprehensive, searchable, open-access catalog of digital microscopic images of human cancer types and subtypes, has partnered with PathPresenter, a secure and scalable multi-tenant enterprise pathology workflow software platform, to provide a powerful education resource for individuals and public organizations around the world involved in cancer care and...

Read more

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

September 17, 2024 8:30 AM

BOULDER, CO / ACCESSWIRE / September 17, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced it has received a new 510(k) clearance from the U.S. Food and...

Read more

Tenon Medical, Inc. Announces Closing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

September 17, 2024 8:30 AM

LOS GATOS, CA / ACCESSWIRE / September 17, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced the closing of its previously announced "reasonable best efforts" public offering with a single health-care focused institutional investor for the purchase and sale of 1,222,850 shares of common stock (or pre-funded...

Read more

Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management

September 17, 2024 8:30 AM

TORONTO, ON / ACCESSWIRE / September 17, 2024 / Ripple Therapeutics today announced a collaboration and option-to-license agreement with AbbVie to develop RTC-620, a next generation, fully biodegradable, sustained release drug delivery intracameral implant with repeat dosing capabilities to reduce intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). This collaboration leverages AbbVie's expertise in...

Read more

CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness

September 17, 2024 8:00 AM

Projected to increase company revenue by 20% in the first year, capitalizing on the booming $18 billion wellness market.SCOTTSDALE, AZ / ACCESSWIRE / September 17, 2024 / CBD Life Sciences, Inc. (CBDL), an innovative leader in the CBD wellness industry, is set to launch a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi...

Read more

Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

September 17, 2024 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / September 17, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing (POCT) and low-dose interferon therapeutics, is pleased to announce that its plans to initiate a clinical study for very low-dose interferon alpha (VELDONA) on treating Human immunodeficiency virus (HIV)-related oral warts at the National Taiwan...

Read more

PMD Device Solutions’ RespiraSense Technology Demonstrates Capability in Predicting 7-Day Mortality

September 17, 2024 7:45 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / September 17, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions AB (Ticker Symbol:PMDS), a leader in digital healthcare technology, today announced the outcome from a recent clinical study that validated the capabilities of its RespiraSense monitoring technology for predicting 7-day mortality.The study which included 402 patients, demonstrated that 4 hours of continuous respiratory rate...

Read more

Phi Huynh, DPM, Joins Modern Foot & Ankle, Expanding Services in Houston, Texas

September 17, 2024 7:15 AM

Modern Foot & Ankle Welcomes Dr. Phi Huynh, DPM: Expanding Specialized Care in Sports Medicine, Diabetic Foot Care, and Surgical Procedures at Houston's Spring and West Oaks Offices.HOUSTON, TX / ACCESSWIRE / September 17, 2024 / Modern Foot & Ankle is pleased to welcome Dr. Phi Huynh, DPM, to its growing Texas podiatry team. Dr. Huynh will be practicing at the Spring and West Oaks offices in Houston, where he will offer specialized care in...

Read more

Angle PLC Announces Notice of Interim Results and Webcast

September 17, 2024 2:00 AM

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, will be releasing its interim results for the six months ended 30 June 2024 on Thursday 26 September 2024.A meeting for analysts will be held at 11:00 am BST on Thursday 26 September 2024 at the offices of Berenberg, 60 Threadneedle Street, London EC2R 8HP.A...

Read more

Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

September 16, 2024 9:00 PM

SAN DIEGO, CA / ACCESSWIRE / September 16, 2024 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 1,912,569 shares of common stock (or pre-funded warrant in lieu thereof) and accompanying...

Read more

Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules

September 16, 2024 8:05 PM

SEATTLE, WA / ACCESSWIRE / September 16, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that it has entered into securities purchase agreements with certain healthcare-focused and institutional investors to purchase (i) 9,090,910 shares of its common stock or...

Read more

Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024

September 16, 2024 5:20 PM

DORADO, PUERTO RICO / ACCESSWIRE / September 16, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the three and nine months ended July 31, 2024 were approximately $2.4...

Read more